logo

For the Inventor, By the Inventor

New York, NY, United States of America

Dang Fang Meng

This inventor holds 8 USPTO granted patents. Top assignee: Sloan-Kettering Institute for Cancer Research. Active years: 2001-2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dang Fang Meng. Retrieved from https://idiyas.com/inventor/dang-fang-meng

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 8

% Patents Active = 62.5

Average Co-Inventor Count = 9.0

ph-index = 5

Forward Citations = 126(Granted Patents)


Company Filing History:

goldMedal8 out of 519 
 
Sloan-Kettering Institute for Cancer Research
 patents

Years Active: 2001-2010

Loading Chart...
8 patents (USPTO):Explore Patents
1. 7750164 - Synthesis of epothilones, intermediates thereto, analogues and uses thereof (2010-07-06),
2. 6849651 - Synthesis of epothilones, intermediates thereto, analogues and uses thereof (2005-02-01),
3. 6828340 - Synthesis of epothilones, intermediates thereto, analogues and uses thereof (2004-12-07),
4. 6723854 - Synthesis of epothilones, intermediates thereto, analogues and uses thereof (2004-04-20),
5. 6656961 - Synthesis of epothilones, intermediates thereto, analogues and uses thereof (2003-12-02),
6. 6369234 - Synthesis of epothilones, intermediates thereto, analogues and uses thereof (2002-04-09),
7. 6300355 - Synthesis of epothilones, intermediates thereto, analogues and uses thereof (2001-10-09),
8. 6242469 - Synthesis of epothilones, intermediates thereto, analogues and uses thereof (2001-06-05),

Title: The Innovative Contributions of Dang Fang Meng in Cancer Research

Introduction

Dang Fang Meng, an accomplished inventor based in New York, NY, has made significant strides in the field of cancer research. With a remarkable portfolio of 8 patents, he has established himself as a leading figure in the development of innovative therapies aimed at combating cancer, particularly in cases that have developed multidrug-resistant phenotypes.

Latest Patents

Among his latest patents, Dang Fang Meng has contributed to the synthesis of epothilones, intermediates related to them, analogues, and their uses. One notable invention details convergent processes for preparing epothilone A and B, including desoxyepothilones A and B. The invention further explores analogues associated with epothilone A and B, and intermediates valuable for their synthesis. Remarkably, this work also presents novel compositions based on these analogues and methods for treating cancer, specifically targeting resistant forms of the disease.

Career Highlights

Dang Fang Meng serves at the Sloan-Kettering Institute for Cancer Research, a prestigious institution dedicated to advancing cancer research and treatment. His role there has enabled him to leverage his expertise in the synthesis of critical compounds that could change the landscape of cancer therapies. His innovative approach has garnered attention and respect within the scientific community.

Collaborations

Throughout his career, Dang Fang Meng has worked alongside prominent figures in the field, including Samuel J. Danishefsky and Peter Bertinato. Their collaborative efforts harness diverse expertise and creativity, further enhancing the potential impact of their combined research on fighting cancer.

Conclusion

Dang Fang Meng's contributions to cancer research through his inventions and collaborations highlight the vital role of innovation in addressing one of the most pressing health challenges today. With his ongoing commitment to research, he continues to pave the way for new therapeutic avenues that hold promise for patients battling cancer.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…